Investment Pitches

Pitch Summary:
Paywalled (Planet Fitness is the leading franchisor of low-cost gyms in the United States. At ~40x forward earnings, investors believe the franchise network is healthy and has room to grow. The Bear Cave doesn’t. Update 2/2 - Bear Cave obtained more documents and said the problems are deeper and more widespread.

BSD Analysis:
Planet Fitness relies on continued franchise expansion, but market saturation, rising franchisee costs, and consumer weakness pose threats. With limited white space for new gyms and tightening consumer budgets, the growth model may be peaking.

Pitch Summary:
Twitter thread: We are short $BBAI via put options. The consulting firm’s stock soared 260% on 12 Jan after announcing that subsidiary NuWave won a 10-year $900m IDIQ contract from the US Air Force. The Bloomberg headline got the bulls excited. This bubble will pop.

BSD Analysis:
BigBear.ai is riding the AI theme but with limited differentiation and inconsistent growth. Reliance on low-margin government contracts, ongoing losses, and repeated dilution highlight structural issues. Larger players could crowd it out, leaving little room for durable growth.

Pitch Summary:
Mismanaging investment funds ($2mil of delinquent loans purchased from related parties is completely worthless now); operating cost underestimated; unsuccessful side operations; the company is close to running out of cash; Update 4/4 - Iceberg provided update via Twitter thread.

BSD Analysis:
AREC positions itself as a coal and rare earths supplier but faces dilution, lack of scaled operations, and promotional behavior. Limited production and reliance on financing raise execution concerns. With minimal revenues and questionable disclosures, the story trades more on hype than fundamentals.

Pitch Summary:
The reported 45% gross margin is in fact negative; commodity product in a commodity space with furious competition; Ponzi-like scheme likely ending in bankruptcy; just another synthetic biology narrative; absurd "silicone DNA" chip; price target - zero. Update 8/5/24 - Remained short and disclosed related party transactions and round-tripping.

BSD Analysis:
Twist Bioscience manufactures synthetic DNA for biotech, healthcare, and industrial customers. Bears highlight persistent cash burn, uncertain path to profitability, and reliance on equity raises. The competitive landscape includes established DNA suppliers, while scaling manufacturing profitably remains a challenge. Intellectual property litigation also adds risk. Catalysts/risk checks: order growth from pharma/biotech customers, gross margin trajectory, litigation outcomes, and funding runway. Counterpoints: synthetic biology is a long-term secular theme, but shorts argue TWST remains structurally unprofitable at current scale.

Pitch Summary:
The sole portfolio update for this quarter covers our investment in Uber Technologies, Inc. common stock (NYSE: UBER), a compounder investment. Uber has recovered strongly from pandemic disruptions, with mobility and delivery gross bookings reaching record levels. Profitability has improved materially as incentive spending declined and scale efficiencies emerged. Uber has achieved adjusted EBITDA profitability and is generating free cash flow, with management targeting substantial long-term margin expansion. The company’s diversified demand base, flexible cost structure, and growing membership program support resilience across economic cycles.

BSD Analysis:
Uber kicked off 2026 with record-breaking results, crossing the 200 million monthly active user milestone. For the full year 2025, the company facilitated $193.5 billion in gross bookings and generated $10 billion in free cash flow, cementing its platform’s power. Entering 2026, Uber’s Mobility segment saw 20% growth, while Delivery surged 26%, offsetting a flat Freight performance. The company has set a Q1 2026 gross bookings target of $52.0–$53.5 billion, representing roughly 20% growth on a constant currency basis. A significant strategic pivot for 2026 is Uber's goal to become the world's largest facilitator of autonomous vehicle (AV) trips. Despite a surprise CFO transition in early February, management maintains its three-year growth outlook, supported by $7.6 billion in unrestricted cash and a doubled GAAP operating income.

Pitch Summary:
Paywalled (The site mentioned: Rumble is largely YouTube for hyper-conservatives and it has struggled to move into mainstream content. The company’s key operating metrics appear dubious. Currently trading for ~170x revenue, Rumble shares may be priced to tumble.) Update 1/6/2023 - Follow-up report published. Update 10/5 - Another follow-up published.

BSD Analysis:
Rumble positions itself as a “free speech” alternative to YouTube, monetizing through ads, subscriptions, and creator partnerships. The bear thesis focuses on user quality, monetization challenges, and reliance on political cycles. Engagement metrics are inflated by a small group of politically charged creators, leaving monetization potential limited versus mainstream platforms. Ad inventory is difficult to sell at scale given brand safety concerns, and Rumble’s alternative payment/hosting infrastructure adds to costs. While the platform has found a niche, it lacks the network effects and advertiser trust needed for sustainable profitability. Cash burn remains heavy, and growth has been driven more by culture-war headlines than by broad user adoption.

Pitch Summary:
Four-year-old quantum computing wannabe; the main product has zero sales; highly competitive market with competitors such as IBM, AMZN and GOOGL; $85m acquisition with little value and huge dilution; constant cash burner with weak capital structure; Update 12/6 - Iceberg tweeted the company's $25m equity offering, equal to 1/4 of the market cap. Update 11/28/24 - Reinitiated the short: False PR;

BSD Analysis:
Quantum Computing Inc. reappears here, reinforcing prior bear views. The thesis emphasizes lack of meaningful revenue, questionable technological edge, and reliance on promotional narratives. Compared with better-capitalized quantum peers, QUBT lacks defensible IP and commercialization pathways. Continued equity raises highlight dilution risk in a speculative segment.

Pitch Summary:
The Italian industrial gases company SOL Spa reported sales growth of 22% in the first half, up 19.5% organically. Operating profit grew by 14%, despite the sharp rise in electricity and transportation costs, which are its main expense items. Excluding the cash outflow due to the increase in working capital and the capex for growth in the calculation, Sol has generated more than €120m in the last twelve months, which with a capitalization of €1,400m represents 8.5% of FCFy (and more than 12% if we exclude growth investments), which is extraordinary for a company of this quality.

BSD Analysis:
SOL S.p.A. is capitalizing on a strongly growing industrial gas market, which is projected to reach $157 billion in 2026, driven by the rapid expansion of clean energy and hydrogen applications. The company’s focus on high-purity gases for the electronics and semiconductor sectors is yielding significant margin expansion as global manufacturing moves toward more sophisticated tech localized hubs. Management is integrating Internet of Things (IoT) technology across its distribution network to enhance monitoring, safety, and operational efficiency, reducing "last-mile" logistics costs. SOL’s dual-track growth in medical gases and specialty industrial solutions provides a robust hedge against cyclicality in the broader metallurgical market. With a 9.4% compound annual growth rate in its core sectors, the firm remains a high-quality play on the essential "unseen" building blocks of the modern industrial and healthcare economies.